Last updated on October 2018

Maintenance Treatment of Renal Anemia in Dialysis Subjects


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of molidustat in comparison to darbepoetin alfa in dialysis subjects with renal anemia who are treated with Erythropoiesis-Stimulating Agents (ESAs).

Clinical Study Identifier: NCT03543657

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Oohashi internal medicine circulatory Clinic
Fukuoka, Japan
2.78miles
  Connect »

Bayer Clinical Trials Contact

Ikeda Vascular Access Nephrology Dialysis
Fukuoka, Japan
4.9miles
  Connect »